Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4

Authors

  • Ahmed Yahia Elmowafy Urology and Nephrology Center, Mansoura University, Egypt Author
  • Hanzada Mohamed El Maghrabi Urology and Nephrology Center, Mansoura University, Egypt Author
  • Mohamed Ahmed Zahab Urology and Nephrology Center, Mansoura University, Egypt Author
  • Salwa Mahmoud Elwasif Urology and Nephrology Center, Mansoura University, Egypt Author
  • Mohamed Adel Bakr Urology and Nephrology Center, Mansoura University, Egypt Author

Abstract

Direct antivirals showed dramatic response in hepatitis C virus (HCV) eradication, but their effect on extrahepatic manifestations is still unclear. A 49-year-old woman was referred to us suffering from lower limb edema and frothy urine. Renal biopsy was done and she was diagnosed with HCV-related membranoproliferative glomerulonephritis with cryoglobulinemia. Treatment with interferon plus ribavirin, steroid, and cyclophosphamide was tried but failed. After introduction of a sofosbuvir-based regimen to the treatment, sustained virologic response was achieved and nephrotic syndrome remission was induced successfully. We could conclude that HCV-related membranoproliferative glomerulonephritis with cryoglobulinemia could be treated successfully with immunosuppressive drugs plus sofosbuvir and dacalatasvir.

Downloads

Download data is not yet available.

Downloads

Published

2018-10-15

Issue

Vol. 12 No. 6 (2018): November

Section

CASE REPORT | Kidney Diseases

How to Cite

Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4. (2018). Iranian Journal of Kidney Diseases, 12(6), 382-384. https://ijkd.org/index.php/ijkd/article/view/3902

Most read articles by the same author(s)